Mortality from solid cancers other than lung, liver, and bone in relation to external dose among plutonium and non-plutonium workers in the Mayak Worker Cohort.
Exposure to ionizing radiation has well-documented long-term effects on cancer rates and other health outcomes in humans. While in vitro experimental studies had demonstrated that the nature of some radiation effects depend on both total dose of the radiation and the dose rate (i.e., the pattern of dose distribution over time), the question of whether or not the carcinogenic effect of radiation exposure depends on the dose rate remains unanswered. Another issue of interest concerns whether or not concomitant exposure to external gamma rays and inhaled plutonium aerosols has any effect on the external exposure effects. The analyses of the present paper focus on the risk of solid cancers at sites other than lung, liver, and bone in Mayak workers. Recent findings are reviewed indicating that there is no evidence of plutonium dose response for these cancers in the Mayak worker cohort. Then the evidence for differences in the external dose effects among workers with and without the potential for exposure to alpha particles from inhaled plutonium is examined. It is found that there is no evidence that exposure to plutonium aerosols significantly affects the risk associated with external exposure. While the Mayak external dose risk estimate of an excess relative risk of 0.16 per Gy is somewhat lower than an appropriately normalized risk estimate from the Life Span Study of Japanese atomic bomb survivors, the uncertainties in these estimates preclude concluding that the external dose excess relative risks of this group of solid cancers differ in the two cohorts.
Southern Urals Biophysics Institute, Ozyorsk, Russian Federation. sokolnikov@subi.su.
Mikhail
M
Sokolnikov
Hirosoft International Corporation, Eureka, CA, USA.
Dale
D
Preston
Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Daniel O
DO
Stram
D000328:Adult; D015331:Cohort Studies; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009381:Neoplasms, Radiation-Induced / Q000209:etiology / Q000401:mortality*; D009688:Nuclear Reactors; D016273:Occupational Exposure / Q000009:adverse effects*; D011005:Plutonium / Q000009:adverse effects*; D011829:Radiation Dosage; D012426:Russia
D011005:Plutonium
Cancer risk; DDREF; Dose rate effect; Mayak worker cohort; Radiation exposure
PLoS One. 2015 Feb 26;10(2):e0117784
25719381
Int J Cancer. 1994 Nov 1;59(3):327-38
7927937
Radiat Res. 1999 Oct;152(4):352-63
10477912
Radiat Res. 2000 Sep;154(3):237-45
10956428
Radiat Res. 2000 Jul;154(1):3-11
10856959
Radiat Res. 2000 Sep;154(3):246-52
10956429
Radiat Environ Biophys. 2003 Jul;42(2):129-35
12851829
Radiat Res. 2013 Mar;179(3):332-42
23391147
Int J Cancer. 2008 Aug 15;123(4):905-11
18528867
Radiat Res. 2015 Jul;184(1):56-65
26121228
Radiat Res. 2007 Jul;168(1):1-64
17722996
Radiat Res. 2003 Jun;159(6):787-98
12751962
Radiat Res. 2012 Mar;177(3):229-43
22171960
J Radiol Prot. 1999 Mar;19(1):3-26
10321692
Health Phys. 2013 Apr;104(4):366-78
23439140
Radiat Res. 2004 Nov;162(5):505-16
15624305
Radiat Res. 2005 Nov;164(5):602-11
16238437
Radiat Res. 2013 Feb;179(2):183-9
23289384